Get started
Advanced Micro Devices IncAdvanced Micro Devices IncAdvanced Micro Devices Inc

Advanced Micro Devices Inc

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

AMD trade ideas

$AMD for fun & practice on earningsI do dowsing and read energy in stocks. I really don't have any positive energy in this thing, so decided to give earnings a whirl with a more in depth reading. First thing is the number 46 comes up twice along with 40 and 47. It seems the primary target is 146, however, there's some "magnetism" I guess you'd call it, back to that $120 zone. My last AMD idea that was a total bomb had highlighted into the $125 area, so the fact it's coming again is usually to be respected, it's just a timing issue. One new idea I came up with that did work on TSLA, but isn't tested a whole bunch yet, is to ask for a date in the past that correlates with the next target zone for AMD. So I just did it and get the date of Nov. 15th (last year). As I check my chart for the prices on that date, I see I've actually already asked this question and have a rectangle on the price levels of Nov. 20th. The prices of these 2 dates do overlap, and highlight this $120 area. When I ask what's the low I get 121. So, if you wanted to own AMD shares, I'd definitely consider selling the puts down there and hope I get assigned. Or, just buy it. The price range of the dates is from $116.87 - 121.93. I also asked for a big date to pay attn to and get July 26th. For a closer in date I get 4/12. We'll see!
NASDAQ:AMDShort
by JenRz
AMD - Our short SMASHED! Buyers in fact needed liquidity builtWe predicted this liquidity build by the buyers using our controlled selling orange channel. This morning off of strong selling volume, we gapped down towards the bottom of this channel and are now looking to see how takes control. Can buyers utilize green contination to break us out of orange selling? OR will we see purple tapered controlled buying being utilized by sellers to build more liquidity to then sell off further. Stay tuned! Happy Trading :)
NASDAQ:AMD
by ReigningTrades
2
AMD Update: Still waiting for the retraceWe're still waiting for wave ii to really kick off. Notice we haven't made a new high though? MACD seems reset too and ready for another drop soon. This would mirror AAPL in regard to a move lower in price. AMD is also on neg div on the micros and 1HR chart which supports the count. So far structure carved out what appears to be the a-b waves, and it points to the target box I have drawn. I feel the $120's is our most likely spot for this retrace to end. Until we have more downside action though, I can't refine our target more. When we get more action, I will update. As of now I plan on buying 25-50 shares once we get towards the bottom of this wave ii. Don't forget, beginning February 23rd (this Friday), I will be dramatically changing my posting schedule here on trading view. My last regular post / update will be on that day.
NASDAQ:AMD
by TSuth
1
(MGX)Metagenomi, Inc.: A Genetic Medicine Powerhouse on the RiseNASDAQ:MGX here's an analysis of Metagenomi, Inc.: Chart Data is limited.. Financial Performance: Market Cap: $456.337 million Previous Close: $12.25 52 Week Range: $9.74 - $12.74 Volume: 392,654 Avg. Volume: 1,187,350 Recent News: Introduction: In the dynamic realm of genetic medicine, where breakthroughs hold the promise of revolutionizing healthcare, one company stands out for its pioneering efforts and recent market buzz – Metagenomi, Inc. With a low share price and a scorching-hot market for gene research, investors are eyeing Metagenomi with keen interest. Let's delve into the company's profile, recent developments, and the compelling reasons why it might just be the next big investment opportunity. Company Overview: Metagenomi, Inc., headquartered in Emeryville, California, emerges as a leading player in the gene editing biotechnology sphere. Established in 2016, Metagenomi is dedicated to developing therapeutics using its proprietary metagenomics-derived genome editing toolbox. This arsenal comprises programmable nucleases, base editors, and RNA/DNA-mediated integration systems, positioning the company at the forefront of genetic medicine innovation. Recent IPO and Insider Trading: A recent initial public offering (IPO) catapulted Metagenomi into the spotlight, with 6,250,000 shares of common stock issued at a public offering price of $15.00 per share. Additionally, insider trading activity has surged, with Novo Holdings A/S, a notable insider, acquiring a significant stake of 900,000 shares at a price of $14.47 per share. This insider confidence underscores Metagenomi's potential and serves as a bullish indicator for prospective investors. Financial Performance and Market Positioning: Despite its relatively modest market capitalization of $456.337 million, Metagenomi boasts a compelling growth trajectory. Recent financial data indicates a positive momentum, with total revenue reaching $37.952 million, signaling robust demand for the company's innovative genetic therapies. Furthermore, the company's strategic collaborations with industry giants like ModernaTX, Inc. and Ionis Pharmaceuticals, Inc. underscore its market credibility and growth potential. Gene Research Revolution: Metagenomi's strategic focus on precision genetic medicines aligns perfectly with the burgeoning gene research revolution. As the healthcare landscape increasingly gravitates towards personalized therapies and gene editing technologies, Metagenomi stands poised to capitalize on this paradigm shift. The convergence of cutting-edge science, favorable regulatory tailwinds, and heightened investor interest in genetic medicine positions Metagenomi as a prime beneficiary of the gene research boom. Investment Considerations: While Metagenomi's low share price and the red-hot gene research market present compelling investment opportunities, prudent investors must weigh certain considerations. The biotechnology sector inherently entails high risk and volatility, with clinical trial outcomes, regulatory approvals, and competitive dynamics exerting significant influence on stock performance. Additionally, Metagenomi's status as an early-stage company necessitates a long-term investment horizon and a tolerance for market fluctuations. Conclusion: In conclusion, Metagenomi, Inc. emerges as a compelling investment opportunity in the genetic medicine landscape. With a low share price, recent IPO buzz, and a strategic foothold in the gene research revolution, Metagenomi embodies the quintessential blend of innovation, potential, and market positioning. While investors must exercise due diligence and navigate the inherent risks of the biotechnology sector, Metagenomi's transformative vision and burgeoning market opportunities make it a stock worth watching and potentially adding to one's investment portfolio.
NASDAQ:AMDLong
by OnePunchSolutions
1
Is a Rally Brewing? Technicals Signal Bullish Sentiment for AMDAMD Chart Analysis: Potential Bullish Signal on 4-Hour Timeframe I've observed a potential bullish pennant pattern forming on the 4-hour chart for AMD. This pattern often precedes price breakouts, with a target of $230 based on standard technical analysis measurements. However, it's crucial to remember: Technical analysis is not a guarantee of future results: Past performance doesn't predict future outcomes. Consider this pattern as a possibility, not a certainty. Thorough research is essential: Conduct your own research, analyze fundamental factors, and understand the inherent risks involved before making any investment decisions. Risk management is paramount: Always prioritize risk management strategies like stop-loss orders, regardless of technical signals or price targets.
NASDAQ:AMDLong
by ParabolicP
4
AMD Update: Clarity comes with Larger PictureI have been really looking at AMD lately because it has been on a tear for years now. In 2018 it was trading for under $10 and closed over $172 dollars on Friday! Thats a 1620% return on your investment in 7 years...talk about insane! Last time I posted on AMD I made an hourly chart and I believe I was off by one degree. The main chart you see above is the daily chart but gives us a much better view of price action. I have said many times in the past but let me re-iterate myself, I DO NOT predict timeframes. With EWT, it predicts WHERE price will move but not WHEN. That being said, disregard the times where I placed my labels and concentrate on what price levels they're at. Looking at structure I believe we're in wave (iii) of (5) of ((1)). We hit the 0.786 and bounced down starting what I'm calling wave ii. If this is the case, then we should drop to the target box I have labeled ii. I know this is a decent amount different from my prior post, and I apologize for that. Sometimes the smaller time frames can get messy and complex, thus the reason for the title. After zooming out and looking at price action on the larger timeframe I believe this is the most accurate count. This is a wave ii, and they can be unpredictable. They're either long, short, deep, or shallow and alternate with iv's. This pairs with what I expect to happen from the indices soon. Price has literally doubled in the last 3 months or so too, so I imagine people will be wanting to take some profits. As I said, wave 2's can be shallow, but it isn't uncommon for a move of this nature to drop to the 0.236 which would be @ $114.87 in this case. On the micro's that price point is between the 0.618-0.786 retracement fibs which is also considered a standard retrace for wave 2's of any degree. I have an alert set at $150 which is at the 0.382 retracement fib. At this point I will be looking at buying in possibly. I already have a few trades going through, and I don't want to overextend myself so we will see if I join the trade or not. I will be watching this closely the next few trading days to see what happens. We should get some important clues soon to help guide us further. Yes, I do have my wave (v) of (5) of ((1)) target @ the $450 area. With the craze surrounding AI and how it is going to change our lives very soon, it should come as no surprise to anyone some companies (AMD included) are going to benefit from their positioning in the market sector. When I get more data I will update y'all. Below is the weekly chart showing y'all an even more zoomed out picture. Don't forget, beginning February 23rd, I will be dramatically changing my posting schedule here on trading view. My last regular post / update will be on that day.
NASDAQ:AMD
by TSuth
2
How to BRR 101Refer to my prev AMD post back in Jan for credibility - I predicted run to 158-165 when it was in the 130s (result: ran to 180s). Now we have a buy the dip opportunity after earnings sell off. There is still too much demand for this to tank yet, it wants one more high (at least). Path to targets is the solid black line. Bullish channel its respecting is the dashed blue channel, every time it dips outside of that it gets bought up fast: - Initial target = 187.50 by 2/9/2024 - After that hits it will pullback to around 176 - If 176 can hold as support it will make one final run to 192-199 by early March 2024 Trailing Stop loss is 2 consecutive closes below the dotted red line. Entered Feb 16 175 calls for 3.50 on 1/31/2024 (underlying 167.67)
NASDAQ:AMDLong
by JerryManders
10
Sell to Open 1 Mar 22, 2024 167.5/155 Put Vertical @ $455.00NASDAQ:AMD This is a bullish strategy with limited risk of $795.00 and limited potential reward of $455.00. This strategy will profit if the stock closes above $162.95 by Mar 22, 2024. There is a 58.11% probability this will happen. From a technical perspective, AMD is having a wedge formation and will likely breakthrough with a upward trend momentum. However, I have a mixed feeling about the AMD's fundamental, so instead of playing an aggressive long vertical call, I tend to sell a vertical put to give myself a higher win probability.
NASDAQ:AMDLong
by LukeFenglutong